Proliferative Diabetic Retinopathy (PDR)

DBCOND0056889Cardiovascular DiseasesDisorders of Glucose Metabolism

Proliferative Diabetic Retinopathy (PDR) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Proliferative Diabetic Retinopathy · Diabetic Proliferative Retinopathy · PDR · PDR - Proliferative Diabetic Retinopathy
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT141196007MedDRA10012689UMLSC0011884

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
80Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Proliferative Diabetic Retinopathy (PDR) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In